Bank of America Corp DE lifted its holdings in shares of NxStage Medical, Inc. (NASDAQ:NXTM) by 45.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 48,434 shares of the medical device company’s stock after buying an additional 15,028 shares during the quarter. Bank of America Corp DE’s holdings in NxStage Medical were worth $1,351,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the company. NumerixS Investment Technologies Inc bought a new position in NxStage Medical during the 2nd quarter worth approximately $122,000. Steward Partners Investment Advisory LLC boosted its stake in NxStage Medical by 714.3% during the 2nd quarter. Steward Partners Investment Advisory LLC now owns 5,700 shares of the medical device company’s stock worth $159,000 after acquiring an additional 5,000 shares during the last quarter. Keybank National Association OH bought a new position in NxStage Medical during the 2nd quarter worth approximately $212,000. Quantitative Systematic Strategies LLC bought a new position in NxStage Medical during the 2nd quarter worth approximately $216,000. Finally, Janus Henderson Group PLC bought a new position in NxStage Medical during the 2nd quarter worth approximately $234,000. Institutional investors own 81.19% of the company’s stock.

NXTM has been the topic of several recent analyst reports. BidaskClub lowered shares of NxStage Medical from a “sell” rating to a “strong sell” rating in a research note on Tuesday, September 25th. ValuEngine lowered shares of NxStage Medical from a “buy” rating to a “hold” rating in a research note on Tuesday, August 7th. Finally, Zacks Investment Research lowered shares of NxStage Medical from a “hold” rating to a “sell” rating in a research note on Saturday, August 11th.

NxStage Medical stock opened at $28.85 on Wednesday. NxStage Medical, Inc. has a fifty-two week low of $22.70 and a fifty-two week high of $29.19. The company has a market cap of $1.93 billion, a P/E ratio of -131.14 and a beta of -0.05.

TRADEMARK VIOLATION NOTICE: “Bank of America Corp DE Has $1.35 Million Stake in NxStage Medical, Inc. (NXTM)” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international copyright laws. The original version of this article can be viewed at https://www.thecerbatgem.com/2018/11/14/bank-of-america-corp-de-has-1-35-million-stake-in-nxstage-medical-inc-nxtm.html.

NxStage Medical Company Profile

NxStage Medical, Inc, a medical technology company, develops, manufactures, and markets products and services for patients suffering from chronic or acute kidney failure. Its primary product includes the System One, a portable hemodialysis system, which is used primarily for home hemodialysis and a range of dialysis therapies to deliver in the home setting.

Recommended Story: What factors cause inflation to rise?

Want to see what other hedge funds are holding NXTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NxStage Medical, Inc. (NASDAQ:NXTM).

Institutional Ownership by Quarter for NxStage Medical (NASDAQ:NXTM)

Receive News & Ratings for NxStage Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NxStage Medical and related companies with MarketBeat.com's FREE daily email newsletter.